U.S. Big Pharma, Big Dividends

Bristol-Myers Squibb

Market Cap: US$114.7b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Johnson & Johnson

Market Cap: US$540.7b

Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

Zoetis

Market Cap: US$46.8b

Engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.

Merck

Market Cap: US$280.5b

Operates as a healthcare company worldwide.

Eli Lilly

Market Cap: US$845.8b

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

Pfizer

Market Cap: US$146.4b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Phibro Animal Health

Market Cap: US$2.4b

Operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.